Pfizer gets FDA green light for new shot that can streamline teenagers' vaccinations
Pfizer Inc. PFE, -1.80% said Friday that the U.S. Food and Drug Administration has approved the first five-in-one vaccine designed to protect teenagers and young adults against meningococcal disease.
US FDA approves Pfizer's vaccine for meningococcal disease
The U.S. Food and Drug Administration (FDA) has approved Pfizer's vaccine Penbraya, making it the first shot to protect against five groups of a deadly bacteria that can cause meningitis and blood ...
Pfizer jacks up price of five-day course of COVID drug Paxlovid to $1,400
The new cost of the drug is nearly triple the amount the US government paid during the coronavirus pandemic, according to a report.
Pfizer sets price of COVID-treatment Paxlovid at $1,390
Pfizer (PFE) is pricing a five-day treatment of the COVID-19 drug Paxlovid at $1,390. Yahoo Finance Health Reporter Anjalee Khemlani breaks down how this price may vary for patients as Pfizer works...
Pfizer to more than double price of its COVID antiviral once drug moves to commercial market
Pfizer Inc. will charge $1,390 for a five-day course of its Paxlovid COVID-19 antiviral when the drug moves to the commercial market later this year. That's more than double the amount the company ...
Pfizer wins unconditional EU antitrust okay for $43 bln Seagen buy
U.S. pharmaceutical company Pfizer gained unconditional EU antitrust approval on Thursday for its proposed $43 billion acquisition of cancer drug maker Seagen.
Pfizer more than doubles price of Covid vaccine
Pfizer is to more than double the US price of its Covid-19 antiviral medication Paxlovid as the use of the jab falls. In a statement, Pfizer said the list price before insurance will rise to US$1,3...
Pfizer Will Charge Up To $1,400 For Covid Drug Paxlovid
The pill is designed to treat Covid-19 in adults and pediatric patients with a high risk for developing severe symptoms.
Pfizer to price Covid drug Paxlovid at $1,390 per course
Paxlovid will transition to the private market in November, which comes as demand for Covid vaccines and treatments slumps nationwide.
Pfizer to price COVID-19 drug Paxlovid at $1,400 for five-day course - WSJ
Pfizer will price its COVID-19 drug Paxlovid at nearly $1,400 for a five-day course when it begins the commercial sales later this year, according to the Wall Street Journal on Wednesday.
Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts
Pfizer (NYSE: PFE ) layoffs are a hot topic among traders on Wednesday as they pour over the details of the job cuts. The Pfizer layoffs will see the company reducing its headcount as it deals with...
Pfizer's 4.9% Yield: A Contrarian Buy Near 1-Year Lows
Pfizer's 4.9% Yield: A Contrarian Buy Near 1-Year Lows
Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights
Pfizer (PFE) concluded the recent trading session at $32.75, signifying a -1.56% move from its prior day's close.
Why Pfizer Stock Slipped Today
Two analysts reduced their price targets on the pharmaceutical giant. One cut was deep, the other very shallow.
Pfizer confronts ‘peak of anti-vaccination rhetoric' as shares rebound
Pfizer Inc. PFE, +5.52% on Monday sought to reassure investors that it can slash costs to repair the damage done by underwhelming COVID-19 product sales.
Related Companies